Destination Wealth Management
Source: SEC Form 13F · as of Mar 2026Destination Wealth Management holds 17 biotech & pharma companies tracked by BioSniper, totaling $192.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$192.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 282,650 | $69.1M |
| LLYELI LILLY & Co | 56,684 | $52.1M |
| PFEPFIZER INC | 943,250 | $26.5M |
| ABTABBOTT LABORATORIES | 257,094 | $26.4M |
| ZTSZoetis Inc. | 100,293 | $11.9M |
| NVONovo Nordisk A/S | 41,068 | $1.5M |
| ABBVAbbVie Inc. | 5,478 | $1.2M |
| MRKMerck & Co., Inc. | 6,187 | $744K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,552 | $693K |
| GILDGILEAD SCIENCES, INC. | 4,697 | $655K |
| AMGNAMGEN INC | 1,493 | $525K |
| IDXXIDEXX LABORATORIES INC /DE | 797 | $448K |
| DGXQuest Diagnostics Incorporated | 1,763 | $346K |
| CAHCardinal Health Inc. | 1,211 | $256K |
| MCKMcKesson Corporation | 272 | $236K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 835 | $226K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 20,025 | $70K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.